individual PLT components was undertaken at 36 to 48 hours after donation and tested in the BacT/ALERT system with 8 mL inoculated into each of aerobic and anaerobic culture bottles. Bottles were incubated until the end of the 7-day shelf life and initial reactive bottles were examined for contamination. Bacterial screened timeexpired PLTs were tested as in the screen method.
RESULTS:
From February 2011 to September 2015, a total of 1,239,029 PLT components were screened. Initial-reactive, confirmed-positive, and false-positive rates were 0.37, 0.03, and 0.19%, respectively. Falsenegative cultures, all with Staphylococcus aureus, occurred on four occasions; three were visually detected before transfusion and one confirmed transmission resulted in patient morbidity. The NHSBT screening protocol effectively reduced the number of clinically adverse transfusion transmissions by 90% in this reporting period, compared to a similar time period before implementation. Delayed testing of 4515 timeexpired PLT units after screening revealed no positives.
CONCLUSION:
The implementation of bacterial screening of PLT components with the NHSBT BacT/ ALERT protocol was an effective risk reduction measure and increased the safety of the blood supply.
T ransmission of bacteria to recipients through transfusion of contaminated blood components was first documented more than 60 years ago 1 and remains a major cause of morbidity and mortality in transfusion medicine. In the United States, microbial transmission was one of the leading causes of transfusion-related fatalities reported to the Food and Drug Administration between 2005 and 2014, exceeded only by transfusion-related acute lung injury and hemolytic transfusion reactions. 2, 3 Of a total of 443 transfusionrelated fatalities, 48 were attributed to microbial infections, 33 of which were bacterial, accounting for 7% of fatalities. Platelet (PLT) components were implicated in 88% of all cases. 2, 3 In 2004, professional standards were introduced by the AABB that required measures to limit and detect bacterial contamination in all PLT components. 4 In the United Kingdom, the Serious Hazards of Transfusion (SHOT) hemovigilance scheme reported 40 incidents of bacterial transmission by transfusion between 1996 and 2014, 5 with PLT components accounting for 83% of the cases. Eleven deaths were reported; two involved red blood cell (RBC) units and nine were linked to PLT components.
Since the 1970s, remarkable advances have been made to improve blood safety, particularly through the detection and identification of blood-borne viruses. However, it is only in the past decade that many blood services have implemented interventions specifically to reduce the risk of bacterial contamination of components such as diversion of the first 30 mL of blood at donation and/or improved donor arm disinfection to reduce skin contamination. These methods have been shown to reduce substantially, but not eliminate, bacterial contamination of the unit. 6, 7 Nevertheless, in combination these measures are reported to reduce such contamination in the order of 44% to 77%. 8 The National Health Service Blood and Transplant (NHSBT) in England introduced diversion nationally in 2003 and improved donor arm disinfection in 2007. Between 2006 and 2010, 10 cases of bacterial transmission were reported from NHSBT blood components resulting in four deaths. Seven of these cases involved PLT components and three were fatal. Overall, 10 patients were affected due to split units of the same donation being administered to more than one patient. In addition, there were five "near-miss" cases of PLT units rejected for transfusion by visual inspection, due to the presence of "clumps" in the component, four grew Staphylococcus aureus and one Raoutella planticola (formerly Klebsiella spp.). An increase in reporting of adverse reactions after transfusion was evident in this time period, perhaps due to the implementation of a European Union directive in 2005 of mandatory, rather than previously voluntary, reporting of such events.
In 2011, NHSBT introduced screening of all PLT components for bacteria as a further risk reduction measure. We report here on the first 4 years and 7 months (February 2011-September 2015) of the screening program using an automated microbial detection system.
MATERIALS AND METHODS
Bacterial screening of all PLT components was established in five regional NHSBT sites (Bristol, Manchester, Sheffield, Newcastle, and London). These sites together processed approximately 300,000 PLT products (250,000 apheresis and 50,000 pooled) per annum. The total numbers processed per site per annum ranged from 14,000 (Newcastle) to 99,000 (Bristol).
PLT component production and specification
At the beginning of the screening program (February 2011), PLT products were manufactured at a ratio of 80% apheresis to 20% of pooled units (buffy coat derived from four donations), moving to 60% apheresis and 40% pooled units in 2015. Initially, all PLT products were suspended in 100% plasma, but from February 2015, the use of PLT additive solution (PAS; SSP1, Macopharma) for pooled units was phased in and all manufacturing centers produced pooled PLTs suspended in 65%:35% (PAS:plasma) as of July 2015. All products met the target specification of more than 2.4 3 10 11 /unit PLT count (pH 6.4-7.4) and white blood cell count of less than 5 3 10 6 /unit. Apheresis PLT components were collected with the Trima system (Terumo BCT, Inc.). Mother bags were split into therapeutic doses at 3 to 4 hours postcollection. Buffy coat-pooled PLTs were prepared from four donations.
Screening protocol
Components were held for 36 to 48 hours postdonation before sampling to allow bacteria to grow to sufficient number for detection in the test system. 9,10 A 16-mL sample was taken into a sampling pouch (SampLok sampling kit [16 mL], ITL Corporation), which was attached to the PLT bag with a sterile connection device (TSCDII, Terumo BCT). An 8-mL volume was inoculated into each of aerobic and anaerobic blood product culture bottles of the BacT/ALERT 3D Automated Microbiology Detection System (bioM erieux, Inc.) in a laminar-flow cabinet (Puricore). Before inoculation, the septum of the bottles was disinfected with an alcohol wipe (Sterets, M€ olnlycke Health Care) by operators wearing nonsterile gloves. The weight of packs pre-and postsampling was recorded to verify that units had been sampled and the correct volume had been taken. All component splits, that is, single, double, and triple, were treated in the same manner, but for pediatric components only the split from which the pediatric units were derived was tested. Specific sample identification and control of the process was maintained by barcode labeling and verification stages in the NHSBT blood supply computer system. Bottles were incubated at 36 6 0.58C after inoculation for the remainder of the 7-day shelf life of the component and units were held for 6 hours before release to hospitals. At 6 hours' incubation, negative to date results were sent from BacT/ ALERT to the NHSBT computer system. Final negative results were then released at the end of the incubation period. Positive results were sent to the NHSBT computer system throughout. A positive initial reactive signal from the BacT/ALERT system resulted in the hold, or recall, of all associated components, including RBCs with pooled PLT components. Additional investigation was undertaken if a component had already been transfused, which involved informing the hospital that they may have transfused a potentially contaminated unit so they could monitor the patient accordingly and initiate treatment if required. The hospital was then informed of the result when available from the NHSBT National Bacteriology Laboratory (NBL; Colindale, London).
Confirmatory and reference work
In the event of an initial reactive result from any of the screening sites, the index positive bottle and all other associated bottles from the same donation were removed from the BacT/ALERT system. This was due to the fact that a permanent hold was placed automatically on all components from this donation to ensure patient safety. These were sent together with the index pack and associated units if available to NBL for confirmatory and reference work. At NBL, a sample of culture medium from all initial reactive screening bottles was Gram stained and subcultured onto two Columbia blood agar plates (Oxoid Ltd) for aerobic and anaerobic incubation for up to 48 hours at 35 6 28C. Index units were retested in duplicate by aerobic and anaerobic BacT/ALERT culture (two anaerobic and two aerobic bottles). These were sampled in a Class II microbiology safety cabinet (HERAsafe HSP12, Kendro Laboratory Products). Index units were mixed and a sterile sampling pouch (100 mL; MacoPharma) was connected to the bag with a TSCDII sterile connection device. This was filled with a minimum of 40 mL of sample. BacT/ ALERT bottles were individually inoculated with 8 mL of sample and were incubated for up to 7 days at 36 6 0.58C. In the event of receipt of an empty or low-volume pack, sufficient sterile saline was added to the unit to restore volume before sampling. Pediatric units produced from an apheresis donation were first pooled back together by use of an SCD device to maintain a closed system to mimic the original split.
Confirmatory bottles that flagged positive were removed and subcultured onto duplicate blood agar plates as for initial reactive bottles. Bacteria were identified by standard phenotypic techniques and species identity was confirmed in an automated microbiology system (BD Phoenix 100, Becton Dickinson).
In the event that the index pack was no longer available for testing, associated units were tested, including additional splits from the apheresis donation or the associated RBCs in the case of pooled PLT donations. All associated units were also tested if the index unit was found to be bacterially contaminated. In all cases, associated units were tested as per the index unit, by inoculation of duplicate pairs of BacT/ALERT bottles. Growth of the same species from any unit tested as that isolated from initial reactive screening bottles was interpreted as confirmation of the screening result.
Time-expired PLT components
Unused time-expired PLT components between 8 and 11 days old were tested in NBL from all NHSBT manufacturing sites as per the initial screening protocol (inoculation of a single aerobic and anaerobic BacT/ALERT culture bottle per PLT unit). Initial reactive cultures were confirmed by repeat testing of the unit.
Statistical analysis
Differences in contamination rate values were compared using Fisher's exact test with p values of less than 0.05 denoting significance.
RESULTS
In the period February 2011 to September 2015, a total of 1,239,029 PLT components were screened, comprising 960,470 apheresis and 278,559 pooled donations (ratio 3.4:1; Table 1 ). Initial reactive rates were high in the first few months with rates in February to March 2011 approaching 3% and decreasing markedly to 0.5% by July to September of the same year. A mean rate of 0.37% was observed over the period February 2011 to September 2015, with a rate of 0.19% for the final quarter July to September 2015. In total, 4632 donations were initial reactive and rates were significantly higher for apheresis donations than for pooled PLTs (0.40% vs. 0.29%; p < 0.0001). Of all initial reactive donations, 403 (0.03% of total number screened) were confirmed as positive for bacterial contamination with rates of 0.02 and 0.07% for apheresis and pooled units, respectively (p < 0.0001). Of the remaining initial reactive donations, 2379 (0.19%) proved to be culture negative (false positive) with no bacteria isolated from the signal positive culture bottles or blood products. In total, 1849 results were reported as indeterminate positive (0.04%) or indeterminate negative (0.11%), as defined in Table 1 .
There was a marked difference in initial reactive results for anaerobic and aerobic culture. Table 2 shows that 75.1% of initial reactives flagged positive in the anaerobic bottle alone compared with 21.4% for the aerobic bottle alone; only 3.5% of initial reactives showed growth in both atmospheres. The higher positivity rate for anaerobic over aerobic culture was maintained for 403 confirmed-positive donations with 66.2% showing growth in the anaerobic bottle alone compared with 7.7% in the aerobic bottle alone. The increased sensitivity, but possible nonspecificity, of anaerobic culture was further underlined by the observed rates of indeterminate positive (80.2%) and false-positive (78.9%) results (Table 2) . For apheresis donations, in which all splits were returned to NBL for confirmatory work in the majority of cases, a single split was found to be bacterially contaminated in 53.2 and 47.8% of doubles and triples, respectively (Table 3) .
Among confirmed positive pooled PLT components in which all components (including associated RBC units) were returned for testing, 58.2% were positive in the index unit alone and 33.7% in both index and RBC units. In all cases, bacteria were detected in only one of the four RBC units under test. For pooled PLT components where the index PLT unit was not available for testing, 78 (40.2%) incidents of bacterial contamination were confirmed by testing of the RBC units alone. Tables 4 and 5 list the organisms detected in aerobic and anaerobic bottles confirmed-positive apheresis and pooled PLT units, respectively. In total 403 isolates representative of 39 different species were detected in both types of units (apheresis 208 isolates, 34 species; pooled 195 isolates, 18 species). Isolates of 30 species were recovered from anaerobic culture alone and 16 from aerobic culture alone; 34 species grew in both atmospheres.
Regarding the source of bacterial contamination, it is evident from the species distribution (Tables 4 and 5) that skin flora (74.7%) predominated, followed by oropharyngeal flora (16.4%), and gut and other flora (8.9%). Table 6 gives a breakdown of "clinically significant"' species isolated from confirmed-positive units ranked by their time-todetection range in the BacT/ALERT system. In general, the Gram-negative bacteria were detected rapidly (range, 4-15 hr), with the exception of Campylobacter lari (32 hr).
Three apheresis PLT donations (unit age 5, 4, and 5 days) that were culture-negative on screening (Case 1, September 2013; Case 2, May 2014; Case 3, December 2014) were classed as near misses after health care staff noted visible clumping of material in the packs before transfusion. In Case 1, involving an apheresis donation split into two components, one unit was found by hospital staff to have clumps, but on arrival at NBL none was observed. The other unit was recalled from another hospital location, no clumps were observed at the hospital, but on arrival at NBL clumps were evident. In addition to the near misses, a single case of a confirmed transmission was determined by the clinical team involving a 6-day-old pooled product, which was reported in the screening period. The recipient, an elderly patient with neutropenia, developed rigors and pyrexia within 15 minutes of the start of the transfusion. The patient was treated and recovered after the incident. S. aureus was implicated in all four cases. Delayed testing of 4515 time-expired PLT components after screening revealed no positives.
DISCUSSION
The introduction of routine screening of PLTs for bacterial contamination in February 2011 was marked by a substantially high initial reactive rate of approximately 3% for units screened in the first two months. This finding is consistent with the experience of the Australian Red Cross, 11 which reported an initial reactive rate of 1.06% on introduction of routine screening of PLTs. In the case of NHSBT, the early high initial reactive rate can potentially be attributed to several factors, including the introduction of a new procedure for staff, ambient temperature variation, electrical interference of the automated system, and false positives due to anaerobic bottle loading. Regarding the latter, a substantial number of false-positive reactions were generated from anaerobic bottles after 24 hours of loading. This was also reported by the Irish Blood Service who devised a loading pattern of a maximum of 30 bottles per incubator drawer and refrained from loading additional bottles into the drawer until 48 hours of incubation had passed. 12 The apparent cause of this problem is temperature changes associated with loading of the BacT/ALERT incubator cabinets, which causes false positivity in previously loaded bottles. bioM erieux are at present trying to resolve this. The majority of these factors were addressed within the first few months and as of January 2014, the initial reactive rate has remained consistently below 0.50%, with a mean of 0.37% over the entire screening period. This we believe to be the current operational limit of the system with the NHSBT protocol. As reviewed by Benjamin and McDonald, 13 initial reactive rates reported by other blood services range from 0.05% to 1.06%. They identified several factors that may affect these rates including PLT collection and preparation methods, donor arm disinfection, diversion systems, volume cultured, aerobic or anaerobic culture or both, time to inoculation, and definition of results. Consequently the comparison of PLT contamination rates between blood services remains problematical. The sample volume screened is a compromise between sensitivity of detection and loss of product to the patient. In a theoretical model Wagner and Eder 14 predicted that doubling the sample volume from 4 to 8 mL would increase sensitivity by 25%. The effect of sample volume in practice was examined by Souza and 16 also noted an improvement in sensitivity after an increase in sample volume from 4 to 8 mL. In a more recent model, 17 where the sample volume was considered as a percentage of the pack volume, the authors concluded that if the sample represented 10% of the total pack there would be a 99% chance of detecting a positive unit if 46 cfu were present, but this was reduced to 61% if only 5 cfu were present. However, it is noteworthy that the NHSBT total pack volume ranges from 275 to 344 mL (mean, 310 mL) for pooled unites and 216 to 270 mL (mean, 243 mL) for apheresis units, which gives mean percentage samples of approximately 5 and 7% for pooled and apheresis PLTs, respectively. Over the screening period the confirmed-positive and indeterminate-positive rates remained relatively consistent in the range 0.01 to 0.05 and 0.02% to 0.08%, respectively, regardless of variation in initial reactive rates. This broadly reflects confirmed-positive rates reported by other blood services. 13 The significant higher confirmed positive rate in pooled PLT components (0.07%) compared to apheresis (0.02%) can potentially be attributed to the number of venipunctures performed of four and one, respectively. Comparable confirmed-positive rates in apheresis and pooled PLT components were reported by Koopman and colleagues 18 and Murphy and colleagues, 19 while Schrezenmeier and coworkers 20 and Hsueh and coworkers 21 reported higher rates in apheresis PLTs over pooled units. In the initial screen, 75.1% of the first positive signals were obtained in the anaerobic bottle only compared with 21.4% in the aerobic bottle alone and 3.5% in both atmospheres. It should be noted that our screening policy dictates the removal of all screening bottles for the implicated donation from the BacT/ALERT system once the first bottle has flagged positive, so incubation may not be completed for all bottles for the donation. In the case of reference data, the anaerobic bottle alone gave positive signals for 66.2% of subsequent confirmed positives and 80.2% of indeterminate positives (Table 2) . Many blood services use only an aerobic bottle to reflect the aerobic environment of a PLT bag and the expectation of growth of predominantly aerobic bacteria. Our data suggest that if a single-bottle protocol was preferred, which the authors do not recommend, the anaerobic bottle offers greater range of species detection and more rapid time to detection of positive cultures (Tables 4 and 5 ). However, this is balanced by the finding that initial reactivity in the anaerobic bottle alone was associated with 78.9% of subsequent false positives compared with 20.6% for the aerobic bottle alone and 0.5% in both (Table 2) .
A possible consequence of the NHSBT screening system is the loss of product resulting from false-positive reactions as all initial reactives result in the loss of these units and, in the case of pooled PLTs, the associated RBC products. Repeat testing on BacT/ALERT is not feasible due to the required minimum period of 5 days' incubation on the system to obtain a valid result, by which time the product would have potentially expired. In an unpublished study of BacT/ALERT bottles seeded with defined bacterial numbers, we found that positive signals are most often triggered by counts in excess of 10 5 cfu/mL. We intend to evaluate the feasibility of confirmation of such initial reactive bottles by other rapid methods, such as BacTx, Verax, or flow cytometry. Although these methods lack the high sensitivity of BacT/ALERT, they have been shown to detect bacteria in the range of 10 3 to 10 5 cfu/ mL, which would appear to be adequate for confirmation of positive bottles [22] [23] [24] and allow reloading of negative bottles to resume incubation and prevent unnecessary loss of product, as well as a reduction in reference work. In the NHSBT system, this will require a software change, as currently all units associated with the donation are discarded on an initial reactive result from the BacT/ALERT system. A broad spectrum of bacterial species has been shown to result in patient sepsis after transfusion of a contaminated component, hence the requirement of a screening system to detect such species with high sensitivity. 13 It is clear that despite the donor assessment before blood collection, a number of donations were positive for a wide variety of bacterial species on screening in general agreement with several studies. 18, [25] [26] [27] [28] [29] [30] As expected, the majority were the skin commensals Propionibacterium spp., coagulase-negative staphylococci, and oropharyngeal streptococci. Although P. acnes was once thought to be an innocuous commensal, it has on occasion been associated with various infections and underlying conditions. 31 Likewise, many coagulase-negative staphylococci, notably S. epidermidis, are opportunist pathogens particularly in the immunocompromised and are associated with increased morbidity and occasional mortality in these patients. 32 The finding of 13 different species of streptococci representative of oropharyngeal flora and in a markedly higher frequency in apheresis than pooled units is noteworthy. Possible reasons for this might be the increased time required for collection of apheresis donations compared with single-unit pooled donations and the larger volume of donor blood processed through the blood cell separator system. Two of the most widely used systems reportedly process a mean volume of whole blood of 3.4 to 3.6 L 33 compared with the approximately sevenfold lower volume of 450 mL (610%) of a single blood donation used for preparation of pooled PLTs. Moreover, anecdotal observations suggest that it was sometimes common practice by apheresis donors to consume snacks during a session, which might help to explain the predominance of oropharyngeal organisms due to translocation from the gum margin. Gut-derived contaminants were relatively uncommon accounting for only 8.2% of all confirmed-positive units. As a rule, the Gram-negative bacteria represent the highest risk to recipients from PLT units with the coliform species E. coli, Serratia spp., and K. pneumoniae being particularly hazardous owing to their rapid growth and release of endotoxin in the unit. 34 BacT/ALERT has been shown by NHSBT and other workers to be particularly effective for the detection of these rapid-growing species. 27 It is clear from the data that a number of confirmedpositive units were contaminated with clinically significant species that were likely to result in bloodstream infections in transfused recipients (Table 6 ). In total 53 donations, involving 71 contaminated PLT components, yielded "pathogenic" Gram-positive (n 5 41) or Gramnegative bacteria (n 5 12). Fortunately, due to their rapid initial reactive detection times on testing, none of the components had yet been issued to hospitals.
Identification and review of bacterial species recovered from contaminated units may give insight into possible sources of contamination. Pseudomonas spp. detection may indicate poor manufacturing laboratory hygiene standards and Staphylococcus spp. inadequate donor arm disinfection. However, on occasion, screening may reveal the presence of an organism indicative of underlying pathology in an asymptomatic donor. 35 Lee and colleagues 36 reported on the follow-up of 16 donors whose PLTs yielded S. bovis, two of whom were found to have colonic polyps. Over the screening period, we identified S. bovis in nine donors; subsequent investigation of four donors showed the presence of colonic polyps with and without diverticulitis. Other clinically relevant isolations included three cases of S. constellatus and one of P. micros linked to dental disease in the donor. These findings underline the small but significant public health benefit provided by the screening. Despite the overall efficiency of the screening process, there were four incidents where S. aureus failed to be detected. Three were not transfused due to visual clumps in the PLT bag and one resulted in a transfusion reaction in a patient who subsequently recovered with no major complications. The patient had acute myeloid leukemia and it has been reported that recipients with neutropenia are more likely to have adverse transfusion reactions. 37 Investigation of these incidents revealed no obvious cause, but regrettably the BacT/ALERT bottles used for the initial screen were not retained so it was not possible to verify that they had been inoculated with a sample of the units. Interestingly it was noted (Case 1) that S. aureus appears to form clots and these are then dissolved with release and dispersal of bacteria in the unit. This is probably due to the secretion of vigorous coagulase enzymes which bind to and activate prothrombin leading to clotting of plasma. The clot is subsequently dissolved by the action of a staphylokinase which results in the release and dispersal of the organisms. 38 Similar experiences with undetected Staphylococcus spp. have been reported by others 39 and in one center resulted in three fatalities. 40 In this data set, a possible transmission with S. agalactiae (Group B Streptococcus) was reported. This was not deemed to be a confirmed transmission due to several reasons including mixed colony growth with E. coli was evident, which was indicative of exogenous contamination; screening of units associated with the PLT pool were culture negative; typical signs of a transfusion reaction were not displayed; their reaction was noted as allergic, which the patient had a past history of with transfusion; and typical signs of a transfusion reaction were not displayed. For apheresis donations the NHSBT protocol dictates bacterial screening of all component splits rather than sampling of the mother bag alone. We have demonstrated that for 53% of doubles and 48% of triple splits, only one of the components was shown to be contaminated (Table  3 ). This practice results in a larger portion of the donation being screened in comparison to testing only the mother bag. The time of sampling from donation in the NHSBT protocol is 36 to 48 hours, which allows the proliferation of any bacteria present to sufficient numbers to be detected by the system. Some national blood services sample much earlier in shelf life as was reported from Denmark, 25 where units were sampled more than 3 and less than 30 hours after collection of whole blood, and from the Netherlands, 41 which utilized a 14-to 20-hour period at room temperature before sampling for culture. Apheresis units are split in NHSBT between 3 and 24 hours after collection. Potentially if splitting was delayed it may be possible to test the mother bag, but to attain the current protocol sensitivity, it is envisaged that the same volume will be needed to be sampled, but this warrants further investigation. The repeat testing of unused, initially screened, PLTs beyond their 7-day shelf life provides an indirect measure of the efficiency of the testing protocol in terms of its false-negative rate. No confirmed-positive cultures were found among 4515 delayed tested time-expired PLT components by the NHSBT protocol, which compares favorably with published rates (0.06%-0.22%) from some other centers. 19, 26, 30, 42 Delayed testing of time-expired PLT components is an invaluable tool to determine screen test efficiency and represents the worst-case scenario as organisms in low numbers at the point of screen testing may not be detected, but at the end of shelf life they will have potentially grown to sufficient number to be captured in the sample to be tested. Autosterilization will occur within approximately 24 hours of collection and will not influence the delayed time-expired testing results. In studies with whole blood, contamination has been shown at between 2.2 and 1.5% immediately after collection. 8, 43 This is not reflected in the PLT component rates, which gives an indication on the time and effectiveness of autosterilization. Before the introduction of bacterial screening, the NHSBT delayed time-expired unit confirmed-positive rate was 0.23%, one in 433 between 1999 and 2007 (n 5 25,138). 44 In conclusion, in the period 2006 to 2010, before the introduction of bacterial screening by NHSBT, seven cases of bacterial transmission from PLT components involving 10 patients, with three fatalities, were documented. In addition, five near-miss incidents were reported over this time period. In a comparable period and a similar number of screened units, we have recorded a single confirmed reported bacterial transmission resulting in morbidity, three near misses, and no deaths. Based on these data sets, the NHSBT screening protocol has effectively reduced the number of clinically adverse transfusion transmissions by 90% (10 adverse reactions before screening with one patient affected afterward). Implementation of bacterial screening by NHSBT using the BacT/ALERT system has been shown to be an effective risk reduction measure that has increased the safety of blood supply.
